Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1973 1
2016 2
2019 2
2020 8
2021 6
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Thrombectomy for Basilar Artery Occlusion with Mild Symptoms.
Guenego A, Dargazanli C, Weisenburger-Lile D, Gory B, Richard S, Ducroux C, Piotin M, Blanc R, Labreuche J, Lucas L, Aubertin M, Benali A, Bourcier R, Detraz L, Vannier S, Guillen M, Eugene F, Walker G, Lun R, Consoli A, Lapergue B, Fahed R; ETIS Investigators. Guenego A, et al. World Neurosurg. 2021 May;149:e400-e414. doi: 10.1016/j.wneu.2021.02.010. Epub 2021 Feb 9. World Neurosurg. 2021. PMID: 33578025
Effect of blood pressure variability in the randomized controlled BP TARGET trial.
Maïer B, Gory B, Lapergue B, Sibon I, Escalard S, Kyheng M, Labreuche J, de Havenon A, Petersen N, Anadani M, Gayat E, Boursin P, Ben Maacha M, Desilles JP, Blanc R, Piotin M, Halimi JM, Mazighi M; BP TARGET Investigators. Maïer B, et al. Eur J Neurol. 2022 Mar;29(3):771-781. doi: 10.1111/ene.15194. Epub 2021 Dec 17. Eur J Neurol. 2022. PMID: 34821437 Clinical Trial.
Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial.
Anadani M, Maïer B, Escalard S, Labreuche J, de Havenon A, Sabben C, Lapergue B, Gory B, Richard S, Sibon I, Desilles JP, Blanc R, Piotin M, Mazighi M; of behalf the BP-TARGET Study Group*. Anadani M, et al. Stroke. 2022 Mar;53(3):719-727. doi: 10.1161/STROKEAHA.121.036701. Epub 2022 Feb 3. Stroke. 2022. PMID: 35109685 Free article. Clinical Trial.
MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists.
L'Allinec V, Sibon I, Mazighi M, Labreuche J, Kyheng M, Boissier E, Roy M, Gory B, Dargazanli C, Desal H, Lapergue B, Bourcier R; Endovascular Treatment in Ischemic Stroke Investigators. L'Allinec V, et al. Neurology. 2020 Feb 25;94(8):e842-e850. doi: 10.1212/WNL.0000000000008873. Epub 2020 Jan 20. Neurology. 2020. PMID: 31959707 Clinical Trial.
First-Pass Effect in Basilar Artery Occlusions: Insights From the Endovascular Treatment of Ischemic Stroke Registry.
Aubertin M, Weisenburger-Lile D, Gory B, Richard S, Blanc R, Ducroux C, Piotin M, Labreuche J, Lucas L, Dargazanli C, Benali A, Bourcier R, Detraz L, Vannier S, Guillen M, Eugene F, Walker G, Lun R, Guenego A, Consoli A, Marnat G, Maier B, Lapergue B, Fahed R; ETIS Investigators*. Aubertin M, et al. Stroke. 2021 Dec;52(12):3777-3785. doi: 10.1161/STROKEAHA.120.030237. Epub 2021 Aug 26. Stroke. 2021. PMID: 34433309
24 results